Table 1.
Demographic and clinical data for Grave's ophthalmopathy patients.
| n | % | |
|---|---|---|
| Female/male | 58/30 | 65.9/34.1 |
| Age (y, mean ± SD, range) | 41.5 ± 15.6 (13–73) | |
| Duration of autoimmune thyroid diseases (months, mean ± SD, range) | 35.8 ± 52.3 (1–240) | |
| GO duration (months, mean ± SD, range) | 16.1 ± 23.7 (1–120) | |
| Clinical activity score | ||
| CAS < 3 (cases, %) | 78 | 88.6 |
| CAS ≥ 3 (cases, %) | 10 | 11.4 |
| Clinical severity | ||
| Mild | 30 | 34.1 |
| Moderate-severe | 37 | 42.1 |
| Sight-threatening | 21 | 23.9 |
| Diplopia/no diplopia | 36/52 | 40.9/59.1 |
| Proptosis (mm, mean ± SD, range) | 18.4 ± 2.9 (11–27) | |